" class="no-js "lang="en-US"> Brian Gragnolati - Medtech Alert
Saturday, September 13, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Gragnolati has served as President and CEO of Atlantic Heath System since 2015

Brian Gragnolati

About Brian Gragnolati

Gragnolati has served as President and CEO of Atlantic Heath System since 2015, and is the former Chairman of the Board of Trustees of the AHA.  Prior to his tenure at Atlantic Health, Brian served as Senior Vice President at Johns Hopkins Medicine.  He previously held executive positions at Wellspan Health, University of Vermont Medical Center and Baystate Medical Center in Springfield, MA.

Related Story

Appointments

 Concord Health Partners Adds Healthcare Veteran Brian Gragnolati as Executive Partner | Pharmtech Focus

Concord Health Partners Adds Healthcare Veteran Brian Gragnolati as Executive Partner

July 12 2022

Concord Health Partners (“Concord” or the “Firm”), a healthcare focused investment firm, today announced that […]